Liquid Dosage

Therapeutical Proteins

Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.

The GEA Advantage

As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.

Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.

A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.

As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.

Approfondimenti GEA

Nuovi cibi in tavola: al lavoro per l'alimentazione del futuro

Caffè, cacao, latte, carne, pesce e uova: questi prodotti di prima necessità dipendono fortemente dall'agricoltura intensiva. Grazie allo sviluppo di nuove tecnologie alimentari possiamo optare per alternative più sostenibili....

Innovating patient care with aseptic spray drying

At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology...

Lecitina: da sottoprodotto a risorsa

La lecitina è un prodotto che sta particolarmente a cuore a Patrick Schürmann, Product Sales Manager di GEA. Questa versatile sostanza è passata da un ruolo di supporto a protagonista del mercato altamente competitivo e a basso...

Ricevi notizie da GEA

Resta in contatto con le innovazioni e le storie GEA iscrivendoti alle news di GEA.

Contattaci

Siamo qui per aiutarti! Solo pochi dettagli e saremo in grado di rispondere alla tua richiesta.